Biofrontera (BFRI) vs Optimi Health (OPTH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Optimi Health is the larger company by market cap ($23.4 million vs $13.6 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BFRI | OPTH |
|---|---|---|
| Share price | $0.9188 | $4.09 |
| Market cap | $13.65M | $23.39M |
| 1-day change | -1.77% | 0.00% |
| YTD return | +61.19% | — |
| 1-year return | -9.03% | — |
| Forward P/E | 2.14 | — |
| EPS (TTM) | $-0.43 | $-1.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.66 | $6.40 |
| 52-week low | $0.555 | $4.00 |
| Distance from 52-week high | -44.65% | -36.17% |
| Analyst consensus | none | — |
| Avg. price target upside | +553.03% | — |
| Average volume | 547.45K | 45.35K |
| Shares outstanding | 14.85M | 5.73M |
| Employees | 84 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Biofrontera
BFRI stock →Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions.
Health Care · Biotechnology: Pharmaceutical Preparations · 84 employees
About Optimi Health
OPTH stock →Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
Health Care · Biotechnology: Pharmaceutical Preparations
BFRI vs OPTH FAQ
Which is bigger, Biofrontera or Optimi Health?
Optimi Health (OPTH) is larger, with a market capitalization of $23.39M compared with $13.65M for Biofrontera (BFRI).
Are Biofrontera and Optimi Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.